News | Medical Water, Commercial & Industrial

Mar Cor Purification Given 510(K) Clearance for Minncare® HD Disinfectant for Use in Water System Disinfection in Kidney Dialysis Applications

January 15, 2015

First Disinfectant Cleared by FDA for Water System Disinfection in Hemodialysis

Little Falls, N.J. January 15, 2015 – Mar Cor Purification, Inc. (Mar Cor), a subsidiary of Cantel Medical Corp. (NYSE:CMN) announced today that it has been given 510(k) clearance (K133724) from the FDA for MINNCARE® HD high level disinfectant, the first water system disinfectant granted a medical device clearance for use in hemodialysis applications. MINNCARE HD disinfectant is a proprietary blend of peracetic acid and hydrogen peroxide and is completely biodegradable allowing for easy disposal and reducing environmental impact. The non-medical device version, MINNCARE® Cold Sterilant, is considered the gold standard in water system disinfection and is used daily in a variety of markets and applications.

MINNCARE HD disinfectant was developed to address the critical need for a validated water system disinfectant that is both safe and effective. After developing an effective protocol with the FDA, Mar Cor successfully conducted extensive testing to validate product performance and safety. Together with MINNCARE HD disinfectant, Mar Cor will offer validated test strips for testing strength and to verify that there are no residuals following a disinfection procedure. Both products will be available in early February 2015.

John Rickert, VP Medical Sales, noted, “MINNCARE HD disinfectant eliminates the risk of using unregulated industrial chemicals, such as chlorine bleach, in patient treatment areas. The disinfection protocol is validated, the chemistry has been proven efficacious, and accurate test strips are available to insure dosage, as well as to verify complete rinse-out of the disinfectant. The use of MINNCARE HD disinfectant in a dialysis clinic will help maintain the water system in optimum condition and make it easier for the water system operator to complete an effective disinfection.”

MINNCARE® is a registered trademark of Medivators Inc. (a Cantel Medical Company)

About Cantel Medical Corp.
Cantel Medical Corp. (NYS: CMN) Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. For further information, visit the Cantel website at

About Mar Cor Purification, Inc.

Mar Cor Purification, Inc., a wholly-owned subsidiary of Cantel Medical Corp. (NYSE: CMN), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has service facilities in 30 cities in the United States and Canada including seven ion exchange resin regeneration plants strategically located in Atlanta, Boston, Chicago, Philadelphia, San Antonio, Montreal and Toronto. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distributor network.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel’s filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.

To view the original version on PR Newswire, visit:

SOURCE Cantel Medical Corp.

Share with a Friend or Colleague

Featured Attachments

Bottle of Minncare-HD Water System Disinfectant

Minncare HD Disinfectant

FDA 510(k) Cleared Disinfectant
View Product
minncarehd datasheet thumbnail

Minncare HD Disinfectant Datasheet

(P/N: 3029823)

View Document

More News & Events

Mar Cor 50 Years

Mar Cor Celebrates 50 Years of Excellence

Fifty years ago, Mar Cor opened its doors as a small, regional water service company. Over the years, the company has grown to be a leader in water purification with a global reach and an extensive product and service offering. We have accomplished a lot.


EON-MCP Portable Dialysis System

Mar Cor Launches it’s Newest and Most Advanced Portable Reverse Osmosis Water System

The EON Portable Dialysis Water System produces high-quality medical water for acute and home hemodialysis use.


Cantel Announces Initiatives to Help Fight COVID-19

Cantel Medical Corp. announced today specific areas of focus and associated actions to combat the COVID-19 virus.


COVID-19 Guidance for High Level Surface Disinfectants

Cantel continues to monitor updates from the CDC and WHO on COVID-19.


COVID-19 Statement from Mar Cor

Keeping safe and keeping healthy through the COVID-19 pandemic.


Scroll to Top